These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31820126)

  • 21. Percutaneous Mitral-Valve Intervention for Secondary Mitral Regurgitation: Data From Real-Life.
    Kaddoura R; Al-Badriyeh D; Abushanab D; Al-Hijji M
    Curr Probl Cardiol; 2023 Oct; 48(10):101889. PubMed ID: 37336309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary mitral regurgitation: percutaneous edge-to-edge repair on the cutting edge?
    Kushneriuk D; Haddad H; Basran R; Shavadia JS
    Curr Opin Cardiol; 2019 Mar; 34(2):185-193. PubMed ID: 30575648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial.
    Messika-Zeitoun D; Attias D; Piriou N; Iung B; Armoiry X; Trochu JN; Donal E; Habib G; Cormier B; Guerin P; Lefèvre T; Maucort-Boulch D; Boutitie F; Vahanian A; Riche B; Obadia JF
    Arch Cardiovasc Dis; 2022 Nov; 115(11):545-551. PubMed ID: 36244966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Mack MJ; Abraham WT; Lindenfeld J; Bolling SF; Feldman TE; Grayburn PA; Kapadia SR; McCarthy PM; Lim DS; Udelson JE; Zile MR; Gammie JS; Gillinov AM; Glower DD; Heimansohn DA; Suri RM; Ellis JT; Shu Y; Kar S; Weissman NJ; Stone GW
    Am Heart J; 2018 Nov; 205():1-11. PubMed ID: 30134187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.
    Grayburn PA; Sannino A; Cohen DJ; Kar S; Lim DS; Mishell JM; Whisenant BK; Rinaldi MJ; Kapadia SR; Rajagopal V; Crowley A; Kotinkaduwa LN; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Coll Cardiol; 2020 Sep; 76(9):1007-1014. PubMed ID: 32854834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Functional Mitral Regurgitation in Heart Failure.
    Fabris E; De Luca A; Vitrella G; Stolfo D; Masè M; Korcova R; Merlo M; Rakar S; Van't Hof AWJ; Kedhi E; Perkan A; Sinagra G
    Curr Cardiol Rep; 2019 Nov; 21(11):139. PubMed ID: 31734930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic Outcomes After Transcatheter Leaflet Approximation in Patients With Secondary Mitral Regurgitation: The COAPT Trial.
    Asch FM; Grayburn PA; Siegel RJ; Kar S; Lim DS; Zaroff JG; Mishell JM; Whisenant B; Mack MJ; Lindenfeld J; Abraham WT; Stone GW; Weissman NJ;
    J Am Coll Cardiol; 2019 Dec; 74(24):2969-2979. PubMed ID: 31574303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous treatment of functional mitral regurgitation - Awaiting results of COAPT and MITRA-FR.
    Orban M; Hausleiter J
    Int J Cardiol; 2018 Oct; 269():89-90. PubMed ID: 30049488
    [No Abstract]   [Full Text] [Related]  

  • 30. New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation.
    Packer M; Grayburn PA
    JAMA Cardiol; 2020 Apr; 5(4):469-475. PubMed ID: 32074243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.
    Saxon JT; Cohen DJ; Chhatriwalla AK; Kotinkaduwa LN; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Arnold SV; Stone GW
    JACC Cardiovasc Interv; 2020 Dec; 13(23):2795-2803. PubMed ID: 33303119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial.
    Giustino G; Lindenfeld J; Abraham WT; Kar S; Lim DS; Grayburn PA; Kapadia SR; Cohen DJ; Kotinkaduwa LN; Weissman NJ; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2020 Oct; 13(20):2317-2328. PubMed ID: 33092705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Vein Systolic Flow Reversal and Outcomes in Patients From the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (COAPT) Trial.
    Bohra C; Asch FM; Lerakis S; Little SH; Redfors B; Zhou Z; Li Y; Weissman NJ; Grayburn PA; Kar S; Lim DS; Abraham WT; Lindenfeld J; Mack MJ; Bax JJ; Stone GW
    Struct Heart; 2024 Sep; 8(5):100333. PubMed ID: 39290680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes with percutaneous mitral repair
    Cubero-Gallego H; Hernandez-Vaquero D; Avanzas P; Almendarez M; Adeba A; Lorca R; Rozado J; Escalera A; Silva J; Moris C; Pascual I
    Ann Transl Med; 2020 Aug; 8(15):962. PubMed ID: 32953762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mitral clipping in the treatment of secondary mitral regurgitation].
    Py A; Giannakopoulos G; Adamopoulos D; Rigamonti F; Iglesias JF; Meyer P; Müller H; Noble S
    Rev Med Suisse; 2019 May; 15(652):1067-1071. PubMed ID: 31116521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MITRA-FR and COAPT : Why are the results so different and what are the consequences for the daily routine?].
    Friedrichs K; Rudolph V
    Herz; 2019 Nov; 44(7):592-595. PubMed ID: 31428798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. I prefer the MitraClip in these cases: the 5-year COAPT data.
    Bartorelli AL; Grancini L; Monizzi G; Gallinoro E; Mastrangelo A; Mallia V; Fabbiocchi F; Andreini D
    Eur Heart J Suppl; 2024 Apr; 26(Suppl 1):i6-i10. PubMed ID: 38867865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives.
    Shah M; Jorde UP
    Front Cardiovasc Med; 2019; 6():88. PubMed ID: 31355209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation.
    Obadia JF; Armoiry X; Iung B; Lefèvre T; Mewton N; Messika-Zeitoun D; Cormier B; Berthiller J; Maucort-Boulch D; Boutitie F; Vaz B; Trochu JN; Vahanian A
    EuroIntervention; 2015 Mar; 10(11):1354-60. PubMed ID: 25798568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ; Wang K; Arnold SV; Magnuson EA; Whisenant B; Brieke A; Rinaldi M; Asgar AW; Lindenfeld J; Abraham WT; Mack MJ; Stone GW; Cohen DJ;
    Circulation; 2019 Dec; 140(23):1881-1891. PubMed ID: 31564137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.